Clinical Trials Browser

OTHER × Gestational Trophoblastic Disease × apatinib × Clear all

NCT05139095 2026-02-05

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Phase 2 Recruiting

Gestational Trophoblastic Disease

NCT04047017 2021-07-30

GTN

Phase 2 Completed

Recurrence, Gestational Trophoblastic Disease